Viewing Study NCT00551512


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT00551512
Status: COMPLETED
Last Update Posted: 2017-03-14
First Post: 2007-10-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors
Sponsor: CanBas Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module